
Vice presidential Nominee Kamala Harris has Suspended all In-person Events after Several of her Mask Wearing Campaign staff Tested Positive for COVID19



the staff of the Ridgewood blog
New Brunswick NJ, At Johnson & Johnson has temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant. The participant’s illness is being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board (DSMB) as well as our internal clinical and safety physicians.
Continue reading Johnson & Johnson Temporarily Pauses COVID-19 Vaccine Candidate Clinical Trial

the staff of the Ridgewood blog
Ridgewood NJ, according to Johns Hopkins Center for Health Security ,the US CDC updated its guidance regarding individuals at elevated risk of severe COVID-19 disease and death due to underlying medical conditions, including more detailed information regarding the risk associated with obesity. The previous iteration of the guidance noted that individuals with a body mass index (BMI) of 30 or higher were at elevated risk of severe COVID-19 disease. The most recent update includes multiple categories: obesity (BMI of greater than 30 but less than 40) and severe obesity (BMI of 40 or greater). Additionally, the guidance notes that individuals “having overweight” (BMI of greater than 25 but less than 30) may also be at elevated risk of severe disease. The expanded risk group could potentially mean that 72% of all Americans are at elevated risk of severe disease based solely on their weight. Notably, BMI does not accurately characterize body fat percentage or overweight/obesity in all individuals, but it provides a simplified metric to help categorize risk associated with these conditions.
Continue reading Obesity Leads to elevated risk of severe COVID-19 disease

the staff of the Ridgewood blog
Ridgewood NJ, in a major blow to the draconian lock down imposed by New Jersey Governor Phil Murphy , the World Health Organization has warned leaders against relying on COVID-19 lockdowns to tackle outbreaks — after previously saying countries should be careful how quickly they reopen.
WHO envoy Dr. David Nabarro said such restrictive measures should only be treated as a last resort, the British magazine the Spectator reported .
Continue reading World Health Organization Now Says Lockdowns Make Poor People an Awful Lot Poorer

the staff of the Ridgewood blog
Ridgewood NJ, according to Johns Hopkins Center for Health Security ,nine months into the COVID-19 pandemic, clinicians are observing more well-defined patterns of long-term health consequences for COVID-19 patients. A commentary published in JAMA describes some of the frequently reported manifestations in recovered patients. Although long-term health effects are more likely to be exhibited by patients with more severe disease (e.g., admitted to an intensive care unit), these effects are also being observed in persons with milder illnesses. General fatigue and dyspnea were the most commonly reported long-term sequelae, in addition to general joint and chest pain.
Continue reading Long-term health consequences for COVID-19 patients

the staff of the Ridgewood blog
Ridgewood NJ, according to Johns Hopkins Center for Health Security ,Pharmaceutical manufacturer Eli Lilly submitted an EUA request to the FDA for its monoclonal antibody cocktail as a COVID-19 treatment after clinical trials for the drugs met the target clinical endpoints. Results from a Phase 2 clinical trial indicate that a combination of two of Eli Lilly’s monoclonal antibodies reduced viral load in COVID-19 patients mitigated symptoms and resulted in fewer hospitalizations and emergency department visits. The study included 268 total participants with mild-to-moderate COVID-19 symptoms, 112 of whom received the treatment and 156 who received a placebo. Additionally, a press release issued by the company indicates that no serious adverse events were reported. The company stated that it aims to make 100,000 doses of a single antibody available by the end of October and 1 million by the end of 2020. For the combination therapy, the company hopes to produce 50,000 doses by the end of 2020, and it is collaborating with various external partners to ensure availability for lower-income countries.

Continue reading CDC Reconfirms COVID infections are principally spread through “close contact”

Continue reading President Trump Heads back to the White House

the staff of the Ridgewood blog
Ridgewood NJ, jobs , jobs, jobs in the last jobs report before the November election released Friday, September’s very positive jobs numbers actually confirm that we may be experiencing the most dynamic economic recovery in American history.
In September the US Economy added 661,000 jobs despite some of the best efforts by Governor Murphy and Governor Cuomo and tyrannical lock downs.

Continue reading Johnson & Johnson (J&J) published preliminary findings for COVID19 Vaccine

the staff of the Ridgewood blog
Ridgewood NJ, Governor Phil Murphy held Facebook Live chat with Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases Thursday morning.
That look of Rut-Ro when Dr. Fauci tells you during a live TV show that it’s becoming scientifically safe for your State to reopen.

the staff of the Ridgewood blog
NEW BRUNSWICK NJ, Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development. These results have been submitted to medRxiv and are due to be published online imminently. Based on these results and following discussions with the U.S. Food and Drug Administration (FDA), ENSEMBLE will enroll up to 60,000 volunteers across three continents and will study the safety and efficacy of a single vaccine dose versus placebo in preventing COVID-19.


People have been laid off from their jobs because of COVID-19 recently. Finding a job these days is a bit challenging. We’re going through a new situation, and we’re gradually adapting to it. Part of adapting is finding new jobs online. It took a pandemic to teach us that we can do most, if not all, types of work from home. The problem lies in the hiring process. How can the recruiters and employers trust us when they’ve only seen us online? Here are our tips on how to make yourself credible when applying for an online job.
Continue reading How to Be Credible When Applying for an Online Job
